Navigation Links
Alcohol Drinking Affects Risk Of Colorectal Tumours

Drinking beer and alcohol increases the risk of colorectal tumours, while drinking wine in moderation lowers the risk, according to a study. //

The study, conducted by Joseph C. Anderson, M.D. and colleagues at Stony Brook University, Stony Brook, New York, was meant to examine the impact of regular alcohol consumption on the detection of significant colorectal neoplasia in a screening population.

In the study, 2,291 patients were subject to a survey of drinking habits and a colonoscopic screening for colorectal neoplasia. Colorectal neoplasia is defined as a condition that is at least in partly characterized by the presence of new growths or tumours including adenocarcinoma, high-grade dysplasia, villous tissue, adenomas 1 cm or greater and multiple (>2) adenomas of any size.

Researchers found that those patients who drank more than eight drinks of alcohol or beer per week were more than twice likely to have colorectal neoplasia compared with those who did not drink any servings. It was also found that 20 percent of patients who drank more than eight drinks of alcohol or beer per week had significant colorectal neoplasia.

The results should not be surprising because alcohol is a known carcinogen that can stimulate the growth of cancer. Alcohol can also be metabolized forming another carcinogen called acetaldehyde, which is known to be responsible for hangovers.

However, all alcohol drinks are not made the same. The study found that those who drank one to eight glasses of wine per week were actually 50 percent less likely to have colorectal neoplasia.

Researchers believe that a compound called resveratrol in red wine is responsible for the reduced risk of colorectal tumours. Previous studies have partially revealed the anticancer mechanism for the protective effect of resveratrol.

The USDA and Department of Health suggest women and people over 60 should not drink more than one drink a day, men should not drink more than two drinks a day. They also suggest people who are pregnant, trying to conceive, take medication, or who are under the age 21 should not drink.

Source: American Journal of Gastroenterology
'"/>




Related medicine news :

1. Alcohol shrinks brain
2. Alcohol linked to brain activity
3. Alcohol within the body
4. Alcoholism Drug Fails To Prevent Drinking Relapses
5. Alcoholics are prone to disability
6. Alcohol decreases risk of dementia
7. Alcohol injures stress hormone response
8. Role of wives of Alcoholics
9. Antiseizure Drug in help for Alcoholics
10. Alcohol is no tonic for sleep
11. Alcohol and Sun Don’t Mi
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: